Literature DB >> 7002534

Failure of exogenous insulin to inhibit C-peptide release from the perfused rat pancreas.

R Tanaka, K Shima, N Sawazaki, T Matsuyama, Y Kumahara, N Yanaihara.   

Abstract

In order to ascertain whether insulin secretion is inhibited by insulin per se, the effect of exogenous rat insulin on basal and stimulated rat C-peptide reactivity (CPR) release was studied in the isolated perfused rat pancreas. The pancreas was perfused with a medium containing 20 or 200 ng/ml of rat insulin for a 20 min equilibration period and successively for a 25 to 30 min test period during which time glucose (300 mg/100 ml), tolbutamide (500 micrograms/ml), glucagon (500 ng/ml) or arginine (10 mM) was added as a secretagogue. The concentration of glucose in the basal medium was 60 mg/100 ml. Exogenous insulin did not significantly suppress the basal CPR secretion, nor did it cause a suppression of the peak value or incremental area of CPR while the pancreas was stimulated, but it rather augmented them. No inhibitory effect of exogenous insulin on the basal or stimulated CPR release was noticed in the present study.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002534     DOI: 10.1507/endocrj1954.27.343

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  2 in total

1.  Insulin inhibits its own secretion from isolated, perifused human pancreatic islets.

Authors:  P Marchetti; D W Scharp; M McLear; E H Finke; B Olack; C Swanson; R Giannarelli; R Navalesi; P E Lacy
Journal:  Acta Diabetol       Date:  1995-06       Impact factor: 4.280

2.  In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide.

Authors:  E J Verspohl; M Händel; I Hagenloh; H P Ammon
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.